BDBM200989 1-[4-(3,5-dimethyl-6-oxo-1,6- 4dihydropyridazin--yl)-3-methylphenoxy] isoquinoline-7-carbonitrile::US9540352, example 13
SMILES: Cc1cc(Oc2nccc3ccc(cc23)C#N)ccc1-c1c(C)n[nH]c(=O)c1C
InChI Key: InChIKey=DASJPWLODOGTCC-UHFFFAOYSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D(1A) dopamine receptor (Homo sapiens (Human)) | BDBM200989![]() (1-[4-(3,5-dimethyl-6-oxo-1,6- 4dihydropyridazin--y...) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | 334 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
Pfizer Inc. US Patent | Assay Description The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Dif... | US Patent US9540352 (2017) BindingDB Entry DOI: 10.7270/Q2X34VND | |||||||||||
More data for this Ligand-Target Pair |